Bayer Ag Pk Stock Performance

BAYRY Stock  USD 13.29  0.02  0.15%   
On a scale of 0 to 100, Bayer AG holds a performance score of 21. The firm shows a Beta (market volatility) of 0.63, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bayer AG's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bayer AG is expected to be smaller as well. Please check Bayer AG's sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Bayer AG's price patterns will revert.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Bayer AG PK are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Bayer AG showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow4.2 B
Total Cashflows From Investing Activities855 M
  

Bayer AG Relative Risk vs. Return Landscape

If you would invest  874.00  in Bayer AG PK on November 22, 2025 and sell it today you would earn a total of  455.00  from holding Bayer AG PK or generate 52.06% return on investment over 90 days. Bayer AG PK is currently producing 0.7506% returns and takes up 2.8024% volatility of returns over 90 trading days. Put another way, 25% of traded otc stocks are less volatile than Bayer, and 85% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Bayer AG is expected to generate 3.73 times more return on investment than the market. However, the company is 3.73 times more volatile than its market benchmark. It trades about 0.27 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of risk.

Bayer AG Target Price Odds to finish over Current Price

The tendency of Bayer OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 13.29 90 days 13.29 
about 13.56
Based on a normal probability distribution, the odds of Bayer AG to move above the current price in 90 days from now is about 13.56 (This Bayer AG PK probability density function shows the probability of Bayer OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Bayer AG has a beta of 0.63 suggesting as returns on the market go up, Bayer AG average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bayer AG PK will be expected to be much smaller as well. Additionally Bayer AG PK has an alpha of 0.6624, implying that it can generate a 0.66 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Bayer AG Price Density   
       Price  

Predictive Modules for Bayer AG

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bayer AG PK. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
10.4913.2916.09
Details
Intrinsic
Valuation
LowRealHigh
11.5514.3517.15
Details
Naive
Forecast
LowNextHigh
10.4213.2216.03
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
7.6313.6119.60
Details

Bayer AG Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bayer AG is not an exception. The market had few large corrections towards the Bayer AG's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bayer AG PK, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bayer AG within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.66
β
Beta against Dow Jones0.63
σ
Overall volatility
1.89
Ir
Information ratio 0.21

Bayer AG Fundamentals Growth

Bayer OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Bayer AG, and Bayer AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bayer OTC Stock performance.

About Bayer AG Performance

Evaluating Bayer AG's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Bayer AG has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bayer AG has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States.

Things to note about Bayer AG PK performance evaluation

Checking the ongoing alerts about Bayer AG for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Bayer AG PK help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Bayer AG's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bayer AG's otc stock performance include:
  • Analyzing Bayer AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bayer AG's stock is overvalued or undervalued compared to its peers.
  • Examining Bayer AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bayer AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bayer AG's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Bayer AG's otc stock. These opinions can provide insight into Bayer AG's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bayer AG's otc stock performance is not an exact science, and many factors can impact Bayer AG's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Bayer OTC Stock Analysis

When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.